Close Menu

IP Roundup

Premium

The University of Arkansas of Little Rock has received US Patent No. 7,659,062, "Gene expression profiling of uterine serous papillary carcinomas and ovarian serous papillary tumors." The patent claims oligonucleotide microarrays used to profile and compare gene expression patterns between uterine serous papillary carcinoma and ovarian serous papillary carcinoma or normal endometrial epithelial cells. According to the inventors, mRNA fingerprints identified using the arrays distinguish the more biologically aggressive and chemotherapy resistant USPC from OSPC or NEC.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Elsevier and a Norwegian consortium come to a "read-and-publish" agreement, according to Nature News.

Researchers in France have explored the genetic history of the blue cheese mold, Forbes reports.

The South China Morning Post reports eight genetic testing firms in Hong Kong are under scrutiny for potentially misleading consumers.

In Science this week: platform to diagnose genetic disease in children, lung disease-causing genetic mutation corrected in mice, and more.

May
15
Sponsored by
Thermo Fisher Scientific

This webinar will discuss how Radboud University Medical Center’s Department of Human Genetics is using exon-level copy number variant (CNV) detection by microarray to assist its efforts in constitutional genome testing.